... Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ) — Health Professional Version — National Cancer Institute Choosing the Right Therapy for Patients With Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors — Cancers Multiple Myeloma Medications — International Myeloma Foundation Kyprolis ...
8 Refractory Myeloma Therapies: Know Your Treatment Options
... Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ) — Health Professional Version — National Cancer Institute Choosing the Right Therapy for Patients With Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors — Cancers Multiple Myeloma Medications — International Myeloma Foundation Kyprolis ...
... A person is more at risk of developing blood clots in the veins (deep vein thrombosis) or the lungs (pulmonary embolism) as a result of treatment with drugs in this category.Proteasome InhibitorsProteasome inhibitors include the drugs carfilzomib (Kyprolis) and bortezomib (Boruzu and Velcade), which may be used in combination with chemotherapy. ...
Understanding Heart Disease and Myeloma Treatment
... A person is more at risk of developing blood clots in the veins (deep vein thrombosis) or the lungs (pulmonary embolism) as a result of treatment with drugs in this category.Proteasome InhibitorsProteasome inhibitors include the drugs carfilzomib (Kyprolis) and bortezomib (Boruzu and Velcade), which may be used in combination with chemotherapy. ...
... Examples of proteasome inhibitors include: Kyprolis (carfilzomib) Ninlaro (ixazomib) Velcade (bortezomib) Commonly reported side effects include nausea, vomiting, fatigue, fever, low white blood cell counts, diarrhea, constipation, back pain, and easy bruising or bleeding.BisphosphonatesBone-modifying drugs, such as bisphosphonates and Xgeva (denosumab ...
Medications for Multiple Myeloma: Your Guide
... Examples of proteasome inhibitors include: Kyprolis (carfilzomib) Ninlaro (ixazomib) Velcade (bortezomib) Commonly reported side effects include nausea, vomiting, fatigue, fever, low white blood cell counts, diarrhea, constipation, back pain, and easy bruising or bleeding.BisphosphonatesBone-modifying drugs, such as bisphosphonates and Xgeva (denosumab ...
... These drugs include: Elotuzumab (Empliciti) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Bortezomib (Boruzu and Velcade) Another category of medication called immunomodulatory drugs — which includes lenalidomide (Revlimid) and pomalidomide (Pomalyst) — can help the body fight AL amyloidosis or myeloma. ...
Amyloidosis: How Is It Different From Multiple Myeloma?
... These drugs include: Elotuzumab (Empliciti) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Bortezomib (Boruzu and Velcade) Another category of medication called immunomodulatory drugs — which includes lenalidomide (Revlimid) and pomalidomide (Pomalyst) — can help the body fight AL amyloidosis or myeloma. ...
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
Infections and Myeloma: How To Lower Your Risk
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
... However, many targeted therapies can cause nausea and vomiting.Examples include proteasome inhibitors: Bortezomib (Velcade, Boruzu) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Other types of targeted drugs that may cause nausea include monoclonal antibodies, bispecific T-cell engagers (BiTEs) and nuclear export inhibitors, like selinexor (Xpovio).6. ...
Nausea With Multiple Myeloma: 6 Causes and 7 Tips To Feel Better
... However, many targeted therapies can cause nausea and vomiting.Examples include proteasome inhibitors: Bortezomib (Velcade, Boruzu) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Other types of targeted drugs that may cause nausea include monoclonal antibodies, bispecific T-cell engagers (BiTEs) and nuclear export inhibitors, like selinexor (Xpovio).6. ...
... Examples include proteasome inhibitors like bortezomib (Boruzu and Velcade), carfilzomib (Kyprolis), and ixazomib (Ninlaro), as well as monoclonal antibodies such as daratumumab (Darzalex), elotuzumab (Empliciti), and isatuximab (Sarclisa). Immunomodulatory drugs (iMiDs) — These boost the immune system and slow myeloma cell growth. ...
Can Multiple Myeloma Be Cured? Advances in Research and Survival
... Examples include proteasome inhibitors like bortezomib (Boruzu and Velcade), carfilzomib (Kyprolis), and ixazomib (Ninlaro), as well as monoclonal antibodies such as daratumumab (Darzalex), elotuzumab (Empliciti), and isatuximab (Sarclisa). Immunomodulatory drugs (iMiDs) — These boost the immune system and slow myeloma cell growth. ...
... Available options for RRMM include: Immunomodulatory drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst) Proteasome inhibitors like bortezomib (Boruzu and Velcade) and carfilzomib (Kyprolis) Immunotherapies such as daratumumab (Darzalex) and elotuzumab (Empliciti) Chimeric antigen receptor T-cell therapy (CAR T-cell therapy) These drugs may ...
Bispecific T-Cell Engagers for RRMM: 6 Facts About a New Type of Treatment
... Available options for RRMM include: Immunomodulatory drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst) Proteasome inhibitors like bortezomib (Boruzu and Velcade) and carfilzomib (Kyprolis) Immunotherapies such as daratumumab (Darzalex) and elotuzumab (Empliciti) Chimeric antigen receptor T-cell therapy (CAR T-cell therapy) These drugs may ...
... Treatment options for RRMM include: Immunotherapy with chimeric antigen receptor T-cell therapy using such options as idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti) Proteasome inhibitors like bortezomib, carfilzomib (Kyprolis), and ixazomib (Ninlaro) IMiDs like pomalidomide (Pomalyst) Bispecific T-cell engagers like teclistamab-cqyv ...
What Is the Life Expectancy With Relapsed/Refractory Myeloma?
... Treatment options for RRMM include: Immunotherapy with chimeric antigen receptor T-cell therapy using such options as idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti) Proteasome inhibitors like bortezomib, carfilzomib (Kyprolis), and ixazomib (Ninlaro) IMiDs like pomalidomide (Pomalyst) Bispecific T-cell engagers like teclistamab-cqyv ...
... Here are some common drug combinations that may be prescribed: Bortezomib (Boruzu and Velcade), lenalidomide (Revlimid), and dexamethasone Carfilzomib (Kyprolis), lenalidomide, and dexamethasone Daratumumab (Darzalex), bortezomib, lenalidomide, and dexamethasone Daratumumab, lenalidomide, and dexamethasone Along with these drug therapy differences, ...
Waldenström’s Macroglobulinemia vs. Multiple Myeloma: What’s the Difference?
... Here are some common drug combinations that may be prescribed: Bortezomib (Boruzu and Velcade), lenalidomide (Revlimid), and dexamethasone Carfilzomib (Kyprolis), lenalidomide, and dexamethasone Daratumumab (Darzalex), bortezomib, lenalidomide, and dexamethasone Daratumumab, lenalidomide, and dexamethasone Along with these drug therapy differences, ...
Join
